Aminoacids and derivatives

<p>Applications (R)-Baclofen is the R-Enantiomer of Baclofen, a specific GABA-B receptor agonist and a muscle relaxant (1,2).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References (1) Brogden, R.N., et al.: Drugs, 8,1 (1974) (2) Song, Y., et al.: Endocrinology. en.2016-1776 (2017)<br></p>

<p>Applications Amino acid substitute tumor growth.<br>References Villiers, C.L., et al.: Eur. J. Biochem., 140, 421 (1984);<br></p>

<p>Applications Isotope labelled Glycine is a non-essential amino acid for human development. Glycine is an inhibitory neurotransmitter in spinal cord, allosteric regulator of NMDA receptors.<br>References Scott, D., et al.: J. Neurosci., 21, 3063 (2001), Laube, B., et al.: Neuropharmacology, 47, 994 (2004), Papadakis, M., et al.: J. Biol. Chem., 279, 14703 (2004), Chen, P., et al.: Mol. Pharmacol., 67, 1470 (2005), Wolosker, H., et al.: Mol. Neurobiol., 36, 152 (2007),<br></p>

<p>Applications Labelled Dihydrochloride salt of N1-Acetylspermidine which is an analog of Spermidine (S680400), an antineoplastic.<br>References Bergeron, R. et al.: J. Med. Chem, 40, 1475 (1997);<br></p>

<p>Stability Hygroscopic<br>Applications L-Saccharopine is a product of breakdown of essential amino acid Lysine (L468895). Saccharopine is also part of the α-aminoadipate pathway of fungal lysine biosynthesis.<br>References Higashino, K., et al.: Biochem. Biophys. Res. Commun., 20, 285 (1965); Johansson, E., et al.: Structure, 8, 1037 (2000)<br></p>

<p>Applications Labelled analogue of Glycine, a non-essential amino acid for human development. Glycine is an inhibitory neurotransmitter in spinal cord, allosteric regulator of NMDA receptors.<br>References Scott, D. et al.: J. Neurosci., 21, 3063 (2001); Laube, B. et al.: Neuropharmacology, 47, 994 (2004); Papadakis, M. et al.: J. Biol. Chem., 279, 14703 (2004); Chen, P. et al.: Mol. Pharmacol., 67, 1470 (2005); Wolosker, H. et al.: Mol. Neurobiol., 36, 152 (2007);<br></p>

<p>Applications 3-O-Methylcarbidopa is an impurity of Carbidopa (C175915) with potential use as therapeutic agents to treat hypertension and Parkinson's disease.<br>References Gelber, L. et al.: J. Chrom., 257, 317 (1983); Kallwass, H. et al.: Bioorg. Med. Chem., 2, 557 (1994);<br></p>

<p>Stability Hygroscopic<br>Applications 4-Ethylcatechol is one of the main phenolic off-flavour markers in French ciders.<br>References Alonso-Salces, R., et al.: Anal. Bioanal. Chem., 379, 464 (2004), Xu, Y., et al.: J. Agr. Food Chemi., 55, 3051 (2007),<br></p>

<p>Applications A labelled metabolite of carboxylic acid.<br>References Bardsley, W., et al.: Biochem. J., 122, 557 (1971), Kim, J., et al.: Biosci. Biotechnol. Biochem., 69, 1331 (2005), Kopka, J., et al.: J. Biotechnol., 124, 312 (2006),<br></p>

<p>Stability Very Hygroscopic, Moisture Sensitive<br>Applications 3,4-Dihydroxyphenylglycolaldehyde (Dopegal) is the monoamine oxidase metabolite of dopamine which is toxic of in a concentrated amount and may be a target for Alzheimer or Parkinson’s therapy.<br>References Burke, W. et al.: Neurotoxical., 25, 101 (2004);<br></p>

<p>Applications L-Kynurenine is a tryptophan metabolite which is a precursor of kynurenic acid (K660500) and an antagonist of N-methyl-aspartate receptor.<br>References Swartz, K., et al.: J. Neurosci., 10, 2965 (1990);, Hasegawa, H., et al.: Anal. Bioanal. Chem., 377, 886 (2003); Tsai, Y., et al.: Anal. Biochem., 319, 34 (2003); Mitsuhashi, S., et al.: Anal. Chim. Acta, 584, 315 (2007)<br></p>

<p>Applications Lacosamide is a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lees, G., et al.: Brain Res., 612, 190 (1993), Kuo, C., et al.: Mol. Pharmacol., 51, 1077 (1997), Barton, M., et al.: Epilepsy Res., 47, 217 (2001), Beyreuther, B., et al.: Eur. J. Pharmacol., 539, 64 (2006), Beyreuther, B., et al.: CNS Drug Rev., 13, 21 (2007),<br></p>

<p>Applications trans-4-Hydroxycyclohexylcarboxylic Acid acts as a reagent in the synthetic preparation of pyrazole-pyrimidine preparation as TTK inhibitors and potential antitumors, Preparation and Janus kinase 1 (JAK1)-selective inhibitory activity of benzimidazole derivatives.<br>References Liu, Y., et al.: ACS Med. Chem. Lett., 7, 671 (2016); Kim, H., et al.: Bioorg. Med. Chem. Lett., 26, 3213 (2016)<br></p>

<p>Stability Hygroscopic<br>Applications Antifibrinolytic agent; blocks lysine binding sites of plasminogen. Hemostatic.<br>References Andersson, et al.: Scand. J. Haematol. 2, 230 (1965), Melander, B., et al.: Acta Pharmacol. Toxicol., 22, 340 (1965), Bonnar, J., et al.: Br. Med. J., 313, 579 (1996), Dunn, C.J., et al.: Drugs, 57, 1005 (1999),<br></p>